FDA approves Wellcovorin for ultra-rare disease. The Trump admin touted it as a treatment for autism

The FDA granted expanded approval to Wellcovorin for treating cerebral folate deficiency in children and adults. The drug, previously promoted by the Trump administration as a potential autism treatment, is not approved for autism. The approval focuses solely on the rare genetic condition CFD.